Identification of the Genes Associated With the Invasion Process and Prognosis for Pancreatic Ductal Adenocarcinoma: Coexpression of MUC16 and Mesothelin

被引:0
|
作者
Hirono, Seiko
Tani, Masaji
Kawai, Manabu
Okada, Ken-ichi
Miyazawa, Motoki
Shimizu, Atsushi
Kitahata, Yuji
Ueno, Masaki
Hayami, Shinya
Shigekawa, Yoshinobu
Yamaue, Hiroki
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu2024
引用
收藏
页码:S1098 / S1098
页数:1
相关论文
共 50 条
  • [21] Immunotherapy for KRAS Positive Lung Adenocarcinoma: Mesothelin and CA125 (MUC16) Are Cancer-Antigen Targets
    Hristov, Boris
    Eguchi, Takashi
    Chintala, Navin
    Lu, Shaohua
    Bott, Matthew
    Travis, William
    Jones, David
    Adusumilli, Prasad
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1457 - S1457
  • [22] Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma
    Luo, Yanli
    Qiu, Zhengjun
    Tian, Ling
    Zhu, Guanghui
    Feng, Ye
    Yi, Miaoying
    Chen, Xiafang
    Wang, Liwei
    Li, Chuanyuan
    Huang, Qian
    HUMAN PATHOLOGY, 2013, 44 (01) : 69 - 76
  • [23] Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma
    Jiang, Bing
    Gu, Yonghong
    Chen, Yuxiang
    CANCER INVESTIGATION, 2014, 32 (06) : 218 - 225
  • [24] Molecular markers associated with perineural invasion in pancreatic ductal adenocarcinoma
    Zhang, Junfeng
    Fu, Xueliang
    Liu, Dejun
    Yang, Minwei
    Yang, Jianyu
    Huo, Yanmiao
    Liu, Wei
    Hua, Rong
    Sun, Yongwei
    Wang, Jian
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [25] MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients
    Ferrer, V. P.
    CANCER GENETICS, 2023, 270 : 22 - 30
  • [26] Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma
    Wang, Wentao
    Zhang, Dongyuan
    Chang, Donglei
    Li, Yupeng
    Ren, Lei
    MOLECULAR AND CELLULAR PROBES, 2023, 67
  • [27] High Mesothelin expression in pancreatic adenocarcinoma is associated with aggressive tumor features but not prognosis
    Hagerty, Brendan L.
    Oshi, Masanori
    Endo, Itaru
    Takabe, Kazuaki
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (09): : 4235 - +
  • [28] Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
    Wu, Huanwen
    Zhu, Liang
    Zhang, Hui
    Shi, Xiaohua
    Zhang, Li
    Wang, Wenze
    Xue, Huadan
    Liang, Zhiyong
    PLOS ONE, 2015, 10 (02):
  • [29] Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma
    Zhang, Shi-Rong
    Li, Hao
    Wang, Wen-Quan
    Jin, Wei
    Xu, Jin-Zhi
    Xu, Hua-Xiang
    Wu, Chun-Tao
    Gao, He-Li
    Li, Shuo
    Li, Tian-Jiao
    Zhang, Wu-Hu
    Xu, Shuai-Shuai
    Ni, Quan-Xing
    Yu, Xian-Jun
    Liu, Lang
    EJSO, 2019, 45 (05): : 769 - 775
  • [30] Immunocytochemistry for MUC4 and MUC16 Is a Useful Adjunct in the Diagnosis of Pancreatic Adenocarcinoma on Fine-Needle Aspiration Cytology
    Horn, Adam
    Chakraborty, Subhankar
    Dey, Parama
    Haridas, Dhanya
    Souchek, Joshua
    Batra, Surinder K.
    Lele, Subodh M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (04) : 546 - 551